Bausch Health Companies Inc.
BHC
$8.52
-$0.01-0.12%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 2.38B | 2.21B | 2.15B | 1.92B | 2.17B |
| Total Other Revenue | 26.00M | 25.00M | 21.00M | 22.00M | 25.00M |
| Total Revenue | 2.41B | 2.24B | 2.17B | 1.94B | 2.19B |
| Cost of Revenue | 705.00M | 623.00M | 649.00M | 582.00M | 652.00M |
| Gross Profit | 1.70B | 1.62B | 1.52B | 1.36B | 1.54B |
| SG&A Expenses | 762.00M | 715.00M | 711.00M | 719.00M | 656.00M |
| Depreciation & Amortization | 282.00M | 253.00M | 269.00M | 273.00M | 313.00M |
| Other Operating Expenses | 0.00 | -- | 1.00M | -- | 2.00M |
| Total Operating Expenses | 1.90B | 1.74B | 1.79B | 1.72B | 1.77B |
| Operating Income | 507.00M | 494.00M | 381.00M | 227.00M | 428.00M |
| Income Before Tax | -7.00M | -326.00M | 79.00M | -136.00M | -357.00M |
| Income Tax Expenses | 40.00M | 56.00M | 52.00M | 73.00M | 53.00M |
| Earnings from Continuing Operations | -47.00M | -382.00M | 27.00M | -209.00M | -410.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.00M | 4.00M | -1.00M | 8.00M | 0.00 |
| Net Income | -39.00M | -378.00M | 26.00M | -201.00M | -410.00M |
| EBIT | 507.00M | 494.00M | 381.00M | 227.00M | 428.00M |
| EBITDA | 836.00M | 795.00M | 696.00M | 546.00M | 788.00M |
| EPS Basic | -0.11 | -1.03 | 0.07 | -0.55 | -1.13 |
| Normalized Basic EPS | 0.26 | 0.27 | 0.08 | -0.12 | 0.20 |
| EPS Diluted | -0.11 | -1.03 | 0.07 | -0.55 | -1.13 |
| Normalized Diluted EPS | 0.26 | 0.27 | 0.08 | -0.12 | 0.20 |
| Average Basic Shares Outstanding | 354.55M | 365.40M | 364.80M | 363.30M | 362.83M |
| Average Diluted Shares Outstanding | 354.55M | 365.40M | 367.10M | 363.30M | 362.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
